Meta-analysis of long-term efficacy on the treatment of unprotected left main coronary artery ;disease

Dong Wang,Jing Wang,Yong Qiao,Chengchun Tang

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.04.028

2014-01-01

Abstract:Objective To compare the long-term efficacy of coronary artery bypass grafting (CABG) with drug-eluting stent (DES) in patients with unprotected left main coronary artery (ULMCA) disease. Methods Pubmed, EMBASE and Cochrane Library Database were searched for clinical studies that reported long-term outcomes comparing DES with CABG on the treatment of ULMCA disease. The data was analyzed by RevMan5. Primary outcomes were death, myocardial infarction, cerebrovascular accident, major adverse cardiac and cerebrovascular events(MACCE) and target vessel revascularization (TVR). Results At more than three-year follow-up, there was no significant difference between the DES and CABG group in the risk of death(RR=0.86, 95% CI 0.67-1.10, P=0.23) and composite endpoint events(RR=0.86, 95% CI 0.61-1.21, P=0.38). The risk of TVR was significantly higher in the DES group(RR=3.67, 95% CI 3.08-4.37, P<0.001). Subgroup analyzes showed that the risk of death(RR=0.74, 95%CI 0.61-0.89, P=0.001) and composite endpoint events(RR=0.64, 95%CI 0.53-0.78, P<0.001) were lower in DES group comparing with CABG group , but the risk of TVR(RR=4.20, 95%CI 3.15-5.60, P<0.001) was still higher in DES group during five-year follow-up. Conclusion DES is associated with favorable outcomes on death and composite endpoint events comparing to CABG with ULMCA disease, but with a higher risk of TVR.